OKLAHOMA CITY – Rep. John Talley, R-Stillwater, has requested an interim study to investigate clinical outcomes of patients with pain following policies resulting in rapid reductions in opioid prescribing.

The study seeks to examine the effects of the restrictions on prescribed pain medication implemented within the state following the enactment of Senate Bill 1446 in Nov. 2018.

Talley said his goal is to bring together researchers, physicians, patients and policy analysts to hear multiple perspectives on the impacts of existing policies and if they have helped reduce opioid addiction in Oklahoma, as well as examine how these changes have affected patients and their ability to access the treatment they need.

“From the start, there should have been metrics in place to measure the clinical outcomes of patients impacted by laws enacted to address the opioids crisis,” Talley said. “It’s my hope that this study, if approved, will allow us to ensure these well-intentioned policies address the real issue while limiting unintended consequences.”

Talley is working with Rep. Ty Burns, R-Pawnee, and Rep. Preston Stinson, R-Edmond, to organize the study.

“This is a complex issue without a one size fits all solution,” Stinson said. “I look forward to hearing from all stakeholders to ensure that our laws are appropriate, safe, and adequate to address patients’ needs.”

The interim study request was filed under the number 21-105. The House Speaker will announce approved interim studies by Friday, July 23.